BLFS
BioLife Solutions Inc
38.60$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.2% | -41.9% | 1.2% | -15.0% | -243.7% | -625.8% | -315.4% | -141.1% | 82.2% | -93.8% | -118.1% | -278.6% | -159.8% | -152.6% | -60.2% | -35.9% | 15.1% | 1.6% | -51.1% | -77.1% | -52.6% | 5.5% | 11.9% | 4.4% | 13.5% | -4.1% | -11.1% | -18.4% | 10.2% | 20.9% | |
| 2.9% | 11.8% | 14.4% | 16.0% | 22.4% | 71.0% | 19.9% | 41.5% | 26.5% | 10.8% | 8.2% | 6.3% | 2.2% | 5.9% | 3.4% | 3.5% | 3.0% | 2.8% | 4.2% | 5.3% | 4.5% | 3.1% | 1.7% | 6.6% | 10.5% | 10.8% | 21.6% | 18.1% | 6.7% | 4.9% | |
| – | – | – | – | – | – | – | – | – | – | 36,144.4% | 12,127.0% | 5.4% | 6.9% | 7.9% | 8.5% | 3.8% | 2.8% | 3.7% | 7.9% | 9.4% | 11.5% | 7.7% | 11.1% | 12.4% | 11.7% | 33.2% | 46.6% | 37.6% | 23.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.6% | 3.8% | 2.8% | 7.7% | 8.5% | 43.8% | 19.9% | 11.1% | 54.8% | -2.5% | -7.5% | 150.6% | – | – | – | |
| 7.7% | -19.4% | 32.5% | 71.9% | -36.1% | 338.7% | -14.1% | -227.1% | 174.3% | -10.5% | 17.7% | -4.5% | 39.1% | 9.3% | 23.7% | 20.2% | 21.0% | 7.0% | -10.1% | -12.3% | -6.5% | 2.7% | -16.8% | -16.3% | -2.3% | -1.9% | -19.6% | 2.2% | 0.3% | -9.3% | |
| 0.4% | 9.9% | 10.5% | 12.4% | 15.6% | 66.1% | 10.3% | 1.9% | 10.5% | 2.5% | 5.9% | 10.9% | 3.5% | 23.6% | 1.4% | 3.4% | 20.3% | 2.6% | 9.5% | 22.0% | 15.3% | 1.3% | 2.5% | 2.5% | 9.6% | 7.0% | 13.6% | 9.4% | 3.9% | 20.5% | |
| -0.5% | -6.9% | -8.6% | -21.5% | -16.9% | -66.1% | 248.9% | -1.9% | -10.5% | 0.6% | -5.9% | -10.9% | -3.5% | -23.6% | -1.4% | -3.3% | -20.3% | -2.6% | -131.4% | 65.7% | 4.8% | -1.3% | -32.9% | -98.7% | -49.4% | -10.6% | -76.2% | 26.2% | 70.9% | -74.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 1.7% | 1.6% | 1.3% | 1.0% | 2.2% | 0.0% | – | – | – | – | – | – | |
| 0.1% | 1.1% | 8.4% | 22.5% | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.6% | 221.0% | 5.7% | 2.0% | 35.7% | -21.5% | 6.4% | 211.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 39.7% | 8.4% | – | 48.5% | 46.5% | 36.5% | 8.9% | -0.3% | 3.6% | 2.0% | -2.4% | 23.4% | -0.7% | -8.0% | -10.4% | |
| 16.7% | 2.7% | 7.9% | 29.4% | 440.6% | 250.6% | 40.7% | 262.0% | -112.6% | 36.8% | 112.9% | 283.1% | 166.5% | 178.8% | 55.0% | 39.7% | 8.4% | 0.6% | 221.0% | 5.7% | 38.5% | 43.5% | 142.6% | 5.8% | 212.3% | -2.3% | 21.4% | 15.6% | -8.2% | -11.4% | |
| 1.0% | -46.1% | 0.5% | -7.2% | 180.1% | -441.4% | -25.8% | 119.0% | -40.9% | -56.4% | -11.0% | -6.4% | 3.2% | 2.6% | -6.5% | 0.5% | 3.2% | -0.4% | 38.5% | -5.7% | -9.3% | 47.7% | 121.5% | -88.4% | 174.7% | -17.3% | -66.1% | 23.5% | 72.9% | -64.8% | |
| -15.7% | -51.8% | -9.3% | -15.0% | -259.3% | -692.0% | -325.7% | -142.9% | 71.7% | -96.2% | -124.0% | -289.5% | -163.3% | -176.2% | -61.5% | -39.3% | -5.2% | -1.0% | -60.6% | -99.1% | -67.9% | 4.2% | 9.4% | 2.0% | 3.9% | -11.1% | -24.8% | -27.8% | 6.3% | 0.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.